The report, titled 'Women at the Centre 2018-19', estimates 1.5 crore additional users of modern contraception since 2012, whereas the current modern contraceptive prevalence rate among women was estimated at 40.2%.
Of the total sterilizations occurred in the district, male constituted even less than one per cent, as per records of chief medical and health officer (CMHO).
The petitioners argued the right of reproductive choice was at the core of liberty and personal autonomy guaranteed under Article 21. Under the law, a woman can terminate her under 12-week-old pregnancy only if a registered medical practitioner certifies that continuance of such pregnancy would pose a grave threat to her mental health or life, or if the foetus is abnormal.
However, civic officials claimed MC had no provision in the act to do vaccination of dog bite patients, as there is only an animal birth control programme in the rules.
The contraceptive called 11-beta-methyl-19-nortestosterone dodecylcarbonate (11-beta-MNTDC) is a modified testosterone that has the combined actions of a male hormone (androgen) and a progesterone.
Under the umbrella of Pratigya Campaign — organisations and individuals promoting women’s rights and access to safe abortion in India — say political parties must prioritise investments in reproductive health.
Scientists are developing reversible male contraceptives inspired by colourful layered cocktails that would be more effective than condoms but not permanent like vasectomies.
U.S.District Judge Wendy Beetlestone in Philadelphia agreed with a lawsuit filed by Pennsylvania, citing the potential harm to states should the rules be enforced.
The Madurai bench of the Madras High Court has directed the authorities concerned to discharge a government doctor from criminal prosecution in a case in which a woman died a year after she was given laughing gas (nitrous oxide) instead of oxygen.
The savings that Bayer - the inventor of aspirin and maker of Yasmin birth control pills - could make as part of the overhaul would give it financial wiggle room as it competes with larger rivals to buy the right to promising treatments from biotech firms.
Go for safer non-surgical birth-control methods, said doctors.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
